DBG
De Burlo Group Portfolio holdings
AUM
$759M
1-Year Return
24.77%
This Quarter Return
-4.33%
1 Year Return
+24.77%
3 Year Return
+146.35%
5 Year Return
+326.03%
10 Year Return
+1,922.48%
AUM
$420M
AUM Growth
+$69.1M
(+20%)
Cap. Flow
+$85.5M
Cap. Flow
% of AUM
20.35%
Top 10 Holdings %
Top 10 Hldgs %
47.86%
Holding
226
New
142
Increased
26
Reduced
23
Closed
35
Top Buys
| 1 |
UnitedHealth
UNH
|
$22.8M |
| 2 |
Danaher
DHR
|
$21.2M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
$20.7M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$18.1M |
| 5 |
PepsiCo
PEP
|
$16.4M |
Top Sells
| 1 |
McKesson
MCK
|
$33.7M |
| 2 |
Elevance Health
ELV
|
$27.6M |
| 3 |
EOG Resources
EOG
|
$23.5M |
| 4 |
Novo Nordisk
NVO
|
$23.5M |
| 5 |
Coca-Cola
KO
|
$22.9M |
Sector Composition
| 1 | Healthcare | 32.16% |
| 2 | Technology | 23.66% |
| 3 | Consumer Staples | 13.55% |
| 4 | Financials | 10.55% |
| 5 | Industrials | 4.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
JPMorgan Chase
JPM
$835B
| $1.08M | 0.26% |
+10,317
| New | +$1.08M |
|
52
American Water Works
AWK
$27.6B
| $1.03M | 0.25% |
+7,950
| New | +$1.03M |
|
53
Henry Schein
HSIC
$8.22B
| $1.01M | 0.24% |
+15,330
| New | +$1.01M |
|
54
Neurocrine Biosciences
NBIX
$13.9B
| $974K | 0.23% |
+9,167
| New | +$974K |
|
55
Stryker
SYK
$151B
| $940K | 0.22% |
4,643
+3,339
| +256% | +$676K |
|
56
AstraZeneca
AZN
$254B
| $893K | 0.21% |
+16,292
| New | +$893K |
|
57
Verizon
VZ
$186B
| $850K | 0.2% |
22,381
-200,307
| -90% | -$7.61M |
|
58
United Parcel Service
UPS
$71.6B
| $845K | 0.2% |
+5,229
| New | +$845K |
|
59
Steris
STE
$24B
| $840K | 0.2% |
+5,050
| New | +$840K |
|
60
Automatic Data Processing
ADP
$122B
| $822K | 0.2% |
3,634
+299
| +9% | +$67.6K |
|
61
Home Depot
HD
$410B
| $773K | 0.18% |
2,801
+1,851
| +195% | +$511K |
|
62
Cigna
CI
$81.2B
| $670K | 0.16% |
2,413
+1,413
| +141% | +$392K |
|
63
Integra LifeSciences
IART
$1.22B
| $613K | 0.15% |
+14,463
| New | +$613K |
|
64
Sherwin-Williams
SHW
$91.2B
| $584K | 0.14% |
+2,850
| New | +$584K |
|
65
Gilead Sciences
GILD
$140B
| $567K | 0.14% |
+9,198
| New | +$567K |
|
66
Pfizer
PFE
$140B
| $539K | 0.13% |
12,307
+3,267
| +36% | +$143K |
|
67
Reinsurance Group of America
RGA
$13.1B
| $512K | 0.12% |
+4,066
| New | +$512K |
|
68
Union Pacific
UNP
$132B
| $500K | 0.12% |
+2,564
| New | +$500K |
|
69
Arista Networks
ANET
$177B
| $403K | 0.1% |
+14,272
| New | +$403K |
|
70
Ecolab
ECL
$78B
| $383K | 0.09% |
+2,650
| New | +$383K |
|
71
TopBuild
BLD
$12.1B
| $377K | 0.09% |
+2,287
| New | +$377K |
|
72
NextEra Energy, Inc.
NEE
$146B
| $376K | 0.09% |
+4,800
| New | +$376K |
|
73
Hologic
HOLX
$14.8B
| $342K | 0.08% |
+5,300
| New | +$342K |
|
74
Clorox
CLX
$15.2B
| $259K | 0.06% |
2,016
-7,999
| -80% | -$1.03M |
|
75
Zoetis
ZTS
$67.9B
| $222K | 0.05% |
+1,500
| New | +$222K |
|